title: 340B Drug Pricing Program Reform-Reply.
authors.affiliation: Department of Leukemia, MD Anderson Cancer Center, Houston, Texas.
authors.forename: Hagop
authors.initials: H
authors.lastname: Kantarjian
authors.affiliation: Division of Hematology and Medical Oncology, Josephine Ford Cancer Institute, Detroit, Michigan.
authors.forename: Robert
authors.initials: R
authors.lastname: Chapman
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D016527:Drug Costs; D006297:Health Services Accessibility / Q000191:economics*; D006801:Humans; D008484:Medicaid / Q000191:economics*; D016345:Medicare Part B / Q000191:economics*; D014493:United States Department of Veterans Affairs / Q000191:economics*
chemical_list: D000970:Antineoplastic Agents